Bevacizumab , as compared with chemotherapy alone , was associated with an increased incidence of hypertension of grade @ or higher ( @ % vs. @ % ) , thromboembolic events of grade @ or higher ( @ % vs. @ % ) , and gastrointestinal fistulas of grade @ or higher ( @ % vs. @ % ) .